Hasbiotech İlaç San. ve Tic. A.Ş participates in International R&D Collaboration Summit and Fair as a Support Sponsor which is held in Pullman Fair and Congress Center between May 3-5, 2017 in order to establish institutional and interpersonal scientific and commercial cooperation grounds integrated with the development objectives of the country and increase national and international awareness of the services and activities including the public, university and private sectors.
The 4th National Hospital and Institutional Pharmacists Congress, which you will find opportunities to evaluate the developing and renewing aspects of the pharmacy profession in the light of scientific and up-to-date information, to examine professional problems and to propose solutions to the authorized institutions and to contribute to professional development, will take place at Hilton Dalaman between 8-12 March 2017.
Our company is a member of IEIS (Pharmaceutical Manufacturers Association of Turkey), which was founded in 1964 and which focuses on improving working conditions in pharmaceutical industry, making contributions to the development of health policies, and realizing many other fundamental objectives as such, at the same time contributing to the industry in general, as of January 3, 2017. Having acquired the vision of marketing the domestic molecule to be discovered in Turkey by Turkish specialists throughout the world, our company wishes to express its appreciation for being given the opportunity to contribute to the activities of IEIS.
Our President Recep Tayyip Erdogan participated in the ceremony organised by Kayseri Chamber of Industry on December 4, 2016 in order to grant awards to well-established companies that contribute to export, employment and development by means of their investments, and said the following:
Thanks to its contribution to “Leadership”, “Quality”, “Innovation” and “Excellency” principles, the Turkish firm Hasbiotech has been granted “2016 International Quality Award” which is accepted as the most prestigious quality award in the world. Having received the award in Frankfurt within a ceremony attended by international leaders, Hasbiotech has been a source of pride for our country.
Ekonomize Magazine held the 8th Economy, Politics and Business World Award Ceremony which is organised traditionally every year. Our company Hasbiotech, carrying out sustainable works in medicine sector, has received “R&D and Innovation Award in medicine Sector”.
Opening its doors to the world in April 2016, Cuba continues to achieve revolutionary developments in the treatment of many diseases with dozens of vaccines, including cancer drugs that it developed with its powerful biotechnology industry despite limited opportunities.
Organized for the 3rd time in 2016, the CPhIİstanbul Pharmaceutical Exhibition will be held between June 1 and 3 at the Istanbul Congress Center, Harbiye. As Hasbiotech İlaç San. ve Tic. A.Ş., we will be present at our stand no: B151. We will be delighted to gather with you at our stand throughout the event.
Dr. Seyfullah Dağıstanlı, our Director General and the Chairman of Pharmacovigilance Association gave a speech during the CPhI Istanbul Exposition that was held on 3-5 June 2015 in Istanbul Congress Center and attended by over 200 companies.
Organized jointly by the Faculty of Engineering of Istanbul Kemerburgaz University, Nanotechnology Center of Sabancı University and Yıldız Techincal University, and sponsored by Hasbiotech, “Nanobiotechnology Days 2015” is held on 14-15 May 2015 in Istanbul Kemerburgaz University’s campus.
17th International Pharmaceutical Technology Symposium (IPTS 2014) was held in Antalya at The Marmara Hotel between September 8 and 10. Cuban Dr. Ernesto Lopes Mola and Dr. Jorge Berlanga-Acosta made presentations at the symposium where recognized and successful speakers attended.
The 4th International Meeting on Pharmacy and Pharmaceutical Sciences sponsored by Hasbiotech together with others was held between September 18 and 21 at the Haydarpaşa Campus of the Marmara University. Our General Manager Dr. Seyfullah Dağıstanlı along with other speakers attended the congress, where Princess of Thailand Chulabhorn, a Professor of Pharmacology, made a presentation.
Transferring technology from Cuba, Hasbiotech İlaç will develop the first Hepatitis C vaccine in Kayseri. In the plant whose foundation will be laid in February, the vaccine developed against Hepatitis C whose treatment costs 18 billion dollars annually all over the world will be sold for 100 dollars.
Hasbiotech has executed a partnership agreement RECOMBIO, a Spanish company specializing in the immunotherapy of cancer and chronic viral diseases.
Turkey is counting the days to manufacture its first ever pharmaceutical molecule. Has Group of Kayseri and Dr. Dağıstanlı will be investing in a molecule to treat Hepatitis C. Dr. Dağıstanlı said “We are very close to the end”.
We will soon be laying the foundations for our biotechnological manufacturing site that will be constructed over 30 thousand square meters in Kayseri.
Original files in JPG, PNG and Vector PDF file formats of our logo are available here.